Jason Wiseman to Neoadjuvant Therapy
This is a "connection" page, showing publications Jason Wiseman has written about Neoadjuvant Therapy.
Connection Strength
1.006
-
Bauer PS, Gamboa AC, Otegbeye EE, Chapman WC, Rivard S, Regenbogen S, Hrebinko KA, Holder-Murray J, Wiseman JT, Ejaz A, Edwards-Hollingsworth K, Hawkins AT, Hunt SR, Balch GC, Wise PE. Short-Course TNT Improves Rectal Tumor Downstaging in a Retrospective Study of the US Rectal Cancer Consortium. J Surg Oncol. 2025 Mar; 131(3):498-506.
Score: 0.225
-
Keilson JM, Gamboa AC, Turgeon MK, Maguire L, Hrebinko K, Holder-Murray J, Wiseman JT, Ejaz A, Hawkins AT, Otegbeye E, Silviera M, Maithel SK, Balch GC. Is There a Role for Adjuvant Chemotherapy in Pathologic Node-Negative Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation Therapy? Ann Surg Oncol. 2023 Jan; 30(1):224-232.
Score: 0.196
-
Turgeon MK, Gamboa AC, Keilson JM, Maniko J, Maguire L, Hrebinko K, Holder-Murray J, Wiseman JT, Abdel-Misih S, Hamdan S, Hawkins AT, Bauer P, Silviera M, Maithel SK, Balch GC. Radiological assessment of persistent retroperitoneal and lateral pelvic lymph nodes after neoadjuvant therapy for rectal cancer: An analysis of the United States Rectal Cancer Consortium. J Surg Oncol. 2021 Oct; 124(5):818-828.
Score: 0.179
-
Wiseman JT, Cloyd JM. Propensity Score Matching: In Reply to Zhang and colleagues. J Am Coll Surg. 2019 10; 229(4):436-437.
Score: 0.159
-
Wiseman JT, Guzman-Pruneda F, Xourafas D, Chun YS, Ejaz A, Tsung A, Pawlik TM, Cloyd JM. Impact of Neoadjuvant Chemotherapy on the Postoperative Outcomes of Patients Undergoing Liver Resection for Colorectal Liver Metastases: A Population-Based Propensity-Matched Analysis. J Am Coll Surg. 2019 07; 229(1):69-77.e2.
Score: 0.153
-
Bauer PS, Gamboa AC, Otegbeye EE, Chapman WC, Rivard S, Regenbogen S, Mohammed M, Holder-Murray J, Wiseman JT, Ejaz A, Edwards-Hollingsworth K, Hawkins AT, Hunt SR, Balch G, Silviera ML. Short-course radiation with consolidation chemotherapy does not increase operative morbidity compared to long-course chemoradiation: A retrospective study of the US rectal cancer consortium. J Surg Oncol. 2024 Feb; 129(2):254-263.
Score: 0.052
-
Gamboa AC, Lee RM, Turgeon MK, Varlamos C, Regenbogen SE, Hrebinko KA, Holder-Murray J, Wiseman JT, Ejaz A, Feng MP, Hawkins AT, Bauer P, Silviera M, Maithel SK, Balch GC. Impact of Postoperative Complications on Oncologic Outcomes After Rectal Cancer Surgery: An Analysis of the US Rectal Cancer Consortium. Ann Surg Oncol. 2021 Mar; 28(3):1712-1721.
Score: 0.042